The JV intends to construct a plant to manufacture non-penicillin and non-cephalosporin Rx drugs and other drugs that are categorised as over-the-counter (OTC) products in Russia. It has also been contemplated to transfer 100 per cent interest in the CJSC Olifen (engaged in production of pharmaceutical substances) being held by Diod to the JV company, subject to due diligence.
1099
2960
279
549
6639
13299
2375
6040
4769
9499
299
480
21000
0
26488
35199
189
1499
1299
1499
3410
3999
1730
3287
3683
0
1298
4998
12585
25170
3469
6899